TIVO-3 Trial Status - 102191


TIVO-3 Trial Status

Cancer-News has 162 videos Subscribe Here

Description: Michael Needle, MD and Chief Medical Officer for AVEO Oncology gives an update for the Phase 3 TIVO-3 trial, a randomized, controlled,
multi-center, open-label study to compare tivozanib to sorafenib in subjects with refractory advanced renal cell carcinoma (RCC).
Shared By : Cancer-News
Posted on : 09/18/17
Added : 2 years ago
Category : Kidney Cancer